Dose Administration Aid Patient Detect Service Protocol October 2015 Version 1.3 Table of Contents Executive Summary... 1 Program objective... 1 Patient qualification... 2 Clinical Service... 2 Reporting/Claiming... 2 Software Information... 3 Program Qualification and Notification... 3 Reporting/Claiming... 3 Patient Decline... 4 Staff roles... 4 Clinical Service Information... 4 Resources... 4 Appendix A: How to report a problem with a medicine or medical device to the Therapeutic Goods Administration... 5 Executive Summary Program objective The GuildCare Dose Administration Aid (DAA) Patient Detect Service program is designed to help pharmacists:
Identify patients who may benefit from having their medicines packed in a DAA, and Generate a personalised patient engagement handout detailing the benefits of the service. Patient qualification GuildCare software will produce a pop-up notification to prompt at the point of dispense for patients on five or more packable medications. Pharmacists can also initiate documentation [ad-hoc] of a service through the GuildCare DAA Patient Detect Service program. Clinical Service The pharmacist will conduct the service in accordance with relevant guidelines and other relevant industry protocols. As part of delivering the DAA Patient Detect Service, Pharmacists are under obligation to adhere to the relevant professional practice standards. This includes but is not limited to applying professional judgement to identify, record and report potential or actual medication related problems that are likely to be clinically significant for the patient (e.g. interactions, contraindications, incompatibilities, allergies, adverse drug reactions) to the patient s Medical Practitioner, the Therapeutic Goods Administration and any other relevant entity. (For further information see Appendix A: How to report a problem with a medicine or medical device to the Therapeutic Goods Administration). Reporting/Claiming Reporting for the GuildCare DAA Patient Detect Service can be found under the Services Summary Report. This report is accessed via the GuildCare Documentation tab under Reports'. DAA Patient Detect Service Version 1.3 October 2015 GuildLink Pty Ltd 2
Software Information Program Qualification and Notification Two ways: 1. The patient requests or pharmacy invites patient as required [Ad-hoc] e.g. Mrs Jones is taking 6 different tablets and often forgets when she needs to take each one. Pharmacy invites Mrs Jones to consider a DAA to help manage her medications and provides her with more information about the service. 2. The pharmacy is prompted by software to invite patients five or more packable medications [Prompted] e.g. Mr Smith has five or more packable medications in his dispense history; pharmacy staff are notified by a GuildCare pop-up prompt upon dispense. Ad-hoc If a patient enquires about DAA services or a pharmacist recommends this, the patient can be enrolled in the program Ad-hoc at any time. If a patient is not already present in the Patients list in the GuildCare software, click Add Patient and follow the on-screen prompts. From the Current Patient tab, Click Add and select Dose Administration Aid from the Professional Service drop-down list then click Enrol. Prompted The GuildCare software will also identify patients by analysing their dispense history. It analyses all available dispense records of your pharmacy only. A pop-up notification will prompt staff at the point of dispense for patients with five or more packable medications based on a list maintained by GuildCare. Reporting/Claiming Reporting for the GuildCare DAA Patient Detect Service can be found under the Services Summary Report. This report is accessed via the GuildCare Documentation tab under Reports'. The GuildCare DAA Patient Detect Service program does not directly attract funding under. Pharmacies must use their dispense software or DAA packing software (e.g. from their packing provider) to accurately report on the number of community patients that use the pharmacy s packing service. Claiming for DAA Services conducted and recorded in accordance with the requirements must be done quarterly through the web portal. Eligible Claiming Periods 1 January to 31 March (approx. 13 weeks) 14 April 1 April to 31 May (approx. 9 weeks) 14 June Claim Due Date 1 June to 30 September (approx. 17 weeks) 14 October 1 October to 31 December (approx. 13 weeks) 14 January DAA Patient Detect Service Version 1.3 October 2015 GuildLink Pty Ltd 3
Patient Decline If the pharmacist does not wish to continue after a DAA Patient Detect Service case has been created, the pharmacist should select Declined as the case status. Staff roles To allow for appropriate workflow and consistent delivery of DAA Patient Detect Services, it is advised to inform and where appropriate train staff members about the service the pharmacy is providing patients and their role in the process. Clinical Service Information It is likely that each patient s drug related needs will be different. The pharmacists must apply their clinical knowledge to the patient s situation and provide appropriate advice, information and recommendation(s) as they see fit. The skills and knowledge required to conduct DAA packing services are developed through training external to GuildCare (see Resources for more information). The GuildCare DAA Patient Detect Service program is designed to help pharmacists identify patients who may benefit from having their medications packed, and generate a personalised patient engagement handout. The pharmacist conducts the following as part of each service: Complete the patient engagement handout from the Documentation tab of the GuildCare DAA Patient Detect Service program Record any additional information which may be of benefit to the patient in relation to the pharmacy s DAA service. Suggested information includes: o Cost of the service on top of their usual medicines costs o That other customers benefit from having their medicines packed o That the pharmacy can show them a sample of what the pack looks like and how to use it Provide comments and any other professional Pharmacist Recommendations Click Print and provide the engagement handout to the patient Inform the patient of how the pharmacy s service works Record the outcome after engaging with the patient Resources Title Dose Administration Aids PPI Programmes Specific Guidelines Calculating your DAA Claim - worksheet Standard and Guidelines for Pharmacists providing a DAA Service QCPP T3B Dose Administration Aids Checklist Author/Source Pharmaceutical Society of Australia QCPP Pharmacy Guild of Australia DAA Patient Detect Service Version 1.3 October 2015 GuildLink Pty Ltd 4
Appendix A: How to report a problem with a medicine or medical device to the Therapeutic Goods Administration Information for health professionals Source: http://www.tga.gov.au/hp/problem.htm The Therapeutic Goods Administration (TGA) is a division of the Australian Government Department of Health and Ageing and is responsible for regulating medicines and medical devices. The work of the TGA is based on applying scientific and clinical expertise to ensure that the benefits to consumers outweigh any risks associated with the use of medicines and medical devices. The TGA relies on the public, healthcare professionals and industry to report problems with medicines or medical devices so that the TGA can identify and respond to safety matters. When to report If a patient has experienced or you suspect they may be experiencing an adverse event relating to a medicine or medical device, report the adverse event to the TGA. Suspected adverse events should be reported the first time they occur, as well as any time they occur thereafter. What to report Please report any suspected adverse event that your patient(s) may be experiencing, in particular: serious reactions (e.g. resulting in hospitalisation) unexpected reactions (reactions not consistent with consumer medicine information or labelling) all suspected reactions to medicines recently introduced in Australia all suspected adverse events that may be caused by combinations of medicines (drug interactions) faults with medical devices resulting in an adverse event (keep the faulty equipment until you have contacted the TGA). What to include in your report In your report include (if applicable): basic details of the patient experiencing the adverse event initials, date of birth, gender details of the adverse event or reaction date it occurred, symptoms experienced (including duration), description of device fault resulting in adverse event, treatment required and outcome (if known) details of the medicine or device involved name, description, dose, for a complementary medicine include AUST L number details of any other medicine(s) the patient experiencing the adverse event may be taking. Report a medicine or medical device adverse event to the TGA How to report Report a suspected adverse event directly to the TGA using: GuildCare s Adverse Events Recording module, sent electronically via a web service portal direct to the TGA the TGA website - http://www.tga.gov.au/safety/problem.htm Alternatively: Medicines Phone: 1300 134 237 or 1800 044 114 Email: adr.reports@tga.gov.au Medical devices Phone: 1800 809 361 Email: iris@tga.gov.au DAA Patient Detect Service Version 1.3 October 2015 GuildLink Pty Ltd 5